Soulus Rp Rash and Pain
- Manufacturer
- Pure Source, LLC
- Effective date
- 2023-11-10
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 4
- Source
- legacy-cache
- Hydrated at
- 2026-08-01 21:21:08
Label at a glance#
Contacts and useful links#
Label contents#
Full prescribing information#
SPL UNCLASSIFIED SECTION
Drug Facts
OTC - ACTIVE INGREDIENT SECTION
Active Ingredient
Lidocaine HCl 0.50%
OTC - PURPOSE SECTION
Purpose
Topical Anesthetic
INDICATIONS & USAGE SECTION
For temporary relief of pain and itching associated with minor skin irritations and/or insect bites.
Uses:
WARNINGS SECTION
For external use only. Avoid contact with eyes. Do not apply to open wounds or damaged skin. If symptoms persist for more than seven days, discontinuing use and consult physician.
Warnings:
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
Keep out of reach of children. If swallowed, consult physician. Do not bandage tightly.
OTC - PREGNANCY OR BREAST FEEDING SECTION
If pregnant or breast feeding, contact physician prior to use.
DOSAGE & ADMINISTRATION SECTION
Directions: Apply directly to effected area. Do not use more than four times per day.
INACTIVE INGREDIENT SECTION
Other Ingredients: Other Ingredients: (Organic) Beeswax, Bentonite, Eugenia Caryophyllus (Clove) Flower Oil, Silver Oxide, Simmondsia Chinensis (Jojoba) Seed Oil, Zinc Oxide, Zingiber Officinale (Ginger) Oil.
SPL UNCLASSIFIED SECTION
Made in USA . Distributed by PURE SOURCE, Inc. Miami, Fl 33172. ph (305) 477-8111
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
Soulus Rp
RASH and PAIN
Relieves Skin Irritation and Discomfort
NET WT 1.5oz
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| LIDOCAINE HYDROCHLORIDE | ACTIVE INGREDIENT | V13007Z41A | 1 | |
| LIDOCAINE | ACTIVE MOIETY | 98PI200987 | 1 | |
| BENTONITE | INACTIVE INGREDIENT | A3N5ZCN45C | 1 | |
| CLOVE OIL | INACTIVE INGREDIENT | 578389D6D0 | 1 | |
| GINGER OIL | INACTIVE INGREDIENT | SAS9Z1SVUK | 1 | |
| JOJOBA OIL | INACTIVE INGREDIENT | 724GKU717M | 1 | |
| SILVER OXIDE | INACTIVE INGREDIENT | 897WUN6G6T | 1 | |
| YELLOW WAX | INACTIVE INGREDIENT | 2ZA36H0S2V | 1 | |
| ZINC OXIDE | INACTIVE INGREDIENT | SOI2LOH54Z | 1 |
Products#
Every source-derived product name is available through these pages.
- Soulus Rp Rash and Pain
- LIDOCAINE HYDROCHLORIDE
- YELLOW WAX
- BENTONITE
- CLOVE OIL
- SILVER OXIDE
- JOJOBA OIL
- ZINC OXIDE
- GINGER OIL
- LIDOCAINE
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 65121-100 | 65121-100-01 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| YELLOW WAX | 2ZA36H0S2V | IACT |
| BENTONITE | A3N5ZCN45C | IACT |
| CLOVE OIL | 578389D6D0 | IACT |
| SILVER OXIDE | 897WUN6G6T | IACT |
| JOJOBA OIL | 724GKU717M | IACT |
| ZINC OXIDE | SOI2LOH54Z | IACT |
| GINGER OIL | SAS9Z1SVUK | IACT |
| LIDOCAINE HYDROCHLORIDE | V13007Z41A | ACTIR |
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| BENTONITE | BENTONITE | A3N5ZCN45C | POWDER / TOPICAL | 0.67 mg/mg | ||
| BENTONITE | BENTONITE | A3N5ZCN45C | LOTION / TOPICAL | 5 %w/w | ||
| BENTONITE | BENTONITE | A3N5ZCN45C | POWDER, DENTIFRICE / DENTAL | 0.05 mg/mg | ||
| BENTONITE | BENTONITE | A3N5ZCN45C | SUSPENSION / ORAL | 65 mg/5ml | ||
| CLOVE OIL | CLOVE OIL | 578389D6D0 | ELIXIR / ORAL | 0.42 mg/5ml | ||
| YELLOW WAX | YELLOW WAX | 2ZA36H0S2V | CAPSULE / ORAL | 44 mg | ||
| BENTONITE | BENTONITE | A3N5ZCN45C | TABLET / ORAL | 355 mg | ||
| YELLOW WAX | YELLOW WAX | 2ZA36H0S2V | CAPSULE, EXTENDED RELEASE / ORAL | 80.67 mg | ||
| BENTONITE | BENTONITE | A3N5ZCN45C | SHAMPOO, SUSPENSION / TOPICAL | 3.25 %w/v | ||
| ZINC OXIDE | ZINC OXIDE | SOI2LOH54Z | SOLUTION / RESPIRATORY (INHALATION) | 3.11 %w/v | ||
| BENTONITE | BENTONITE | A3N5ZCN45C | TABLET, COATED / ORAL | 1.8 mg | ||
| YELLOW WAX | YELLOW WAX | 2ZA36H0S2V | TABLET, COATED / ORAL | 213.7 mg | ||
| BENTONITE | BENTONITE | A3N5ZCN45C | CAPSULE / ORAL | ADJ PH | ||
| ZINC OXIDE | ZINC OXIDE | SOI2LOH54Z | INJECTION, SUSPENSION / SUBCUTANEOUS | NA | ||
| YELLOW WAX | YELLOW WAX | 2ZA36H0S2V | TABLET / ORAL | 3.22 mg | ||
| YELLOW WAX | YELLOW WAX | 2ZA36H0S2V | TABLET, SUGAR COATED / ORAL | NA | ||
| YELLOW WAX | YELLOW WAX | 2ZA36H0S2V | OINTMENT / TOPICAL | 20 %w/w | ||
| CLOVE OIL | CLOVE OIL | 578389D6D0 | SUSPENSION / ORAL | 0.1 mg/5ml | ||
| YELLOW WAX | YELLOW WAX | 2ZA36H0S2V | TABLET, DELAYED RELEASE / ORAL | 0.1 mg | ||
| YELLOW WAX | YELLOW WAX | 2ZA36H0S2V | CREAM / TOPICAL | 5 %w/w | ||
| YELLOW WAX | YELLOW WAX | 2ZA36H0S2V | TABLET, EXTENDED RELEASE / ORAL | 0.01 mg | ||
| BENTONITE | BENTONITE | A3N5ZCN45C | CREAM / TOPICAL | 4.1 %w/w | ||
| ZINC OXIDE | ZINC OXIDE | SOI2LOH54Z | SUPPOSITORY / RECTAL | 375 mg | ||
| CLOVE OIL | CLOVE OIL | 578389D6D0 | PASTE, DENTIFRICE / DENTAL | 2.4 %w/w | ||
| BENTONITE | BENTONITE | A3N5ZCN45C | SYSTEM / TRANSDERMAL | 9.86 mg | ||
| ZINC OXIDE | ZINC OXIDE | SOI2LOH54Z | INJECTION / SUBCUTANEOUS | 0.02 %w/v | ||
| ZINC OXIDE | ZINC OXIDE | SOI2LOH54Z | SOLUTION / INTRAVENOUS | 3.11 %w/v | ||
| BENTONITE | BENTONITE | A3N5ZCN45C | SUPPOSITORY / VAGINAL | 288.1 mg | ||
| ZINC OXIDE | ZINC OXIDE | SOI2LOH54Z | LOTION / TOPICAL | 16 %w/w |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 25488951-b229-fccc-e063-6394a90a674b | 5ad3ad36-e814-4707-9f0d-c0be3ad8f166 | 2024-10-25 | Warnings | 5ad3ad36-e814-4707-9f0d-c0be3ad8f166 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
